A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

NCT05337657 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: GB491+Letrozole

Sponsor

Genor Biopharma Co., Ltd.